当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Nature Medicine杂志
Nature Medicine
基本信息
期刊名称 Nature Medicine
NAT MED
期刊ISSN 1078-8956
期刊官方网站 https://www.nature.com/nm
是否OA No
出版商 Nature Research
出版周期 Monthly
文章处理费 登录后查看
始发年份 1995
年文章数 295
影响因子 58.7(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学1区 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学1区
CELL BIOLOGY 细胞生物学1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验1区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 100.9 19.045 8.987
Medicine
General Medicine
3/636 99%
Biochemistry, Genetics and Molecular Biology
General Biochemistry, Genetics and Molecular Biology
2/221 99%
补充信息
自引率 1%
H-index 497
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1078-8956%5BISSN%5D
投稿指南
期刊投稿网址 https://mts-nmed.nature.com/
收稿范围
The criteria for consideration of translational and clinical research in Nature Medicine are originality, timeliness and impact on improving human health by addressing unmet clinical needs. Original research ranges from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative technologies aimed at improving human health.

We consider all types of clinical research, including:

    Case-reports and small case series
    Clinical trials, whether phase 1, 2, 3 or 4
    Observational studies
    Meta-analyses
    Biomarker studies   
    Public and global health studies

Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.

Clinical studies can be submitted in any of our content types. To facilitate the preparation of your clinical study, please review our guidelines and reporting requirements.

Current areas of interest also include, but are not limited to:

    Gene and cell therapies
    Clinical genomics
    Regenerative medicine
    High-definition medicine
    Effects of the environment in human health
    Artificial intelligence in health care
    Smart wearable devices
    Early disease diagnosis
    Microbiome
    Aging

Nature Medicine also publishes Reviews, Perspectives and other content commissioned from leading scientists in their fields to provide expert and contextualized views of the latest research driving the progress of medicine. The Magazine section is editorially independent and provides topical and timely reporting of upcoming trends affecting medicine, researchers and the general audience.
收录体裁
Article, Letter, Technical Report, Brief Communication, Analysis, Resource, Correspondence, Matters Arising, News, opinion, News and Views, Book Reviews, Reviews, Reviews, Commentary, Perspective
投稿指南 https://www.nature.com/nm/submission-guidelines
投稿模板
参考文献格式 https://www.nature.com/nm/for-authors/preparing-your-submission
编辑信息

Chief Editor: Joao Monteiro

Joao received his medical training at the Federal University in Rio de Janeiro, Brazil, where he also earned a PhD degree, studying mechanisms of Treg function and loss of tolerance to self-antigens in autoimmune diseases. Afterwards he was awarded a postdoctoral fellowship from the Pew charitable trusts and joined the lab of Ron Germain, at the National Institutes of Health, USA, to persue studies on T cell antigen recognition and in vivo dynamics of the immune responses. He has been serving the scientific community as a professional editor since 2013, when he joined Cell as the primary editor for immunology and translational medicine. Joao joined Nature Medicine as Chief Editor in December 2017. You can follow him on Twitter @immuno_stuff.

joao.monteiro@us.nature.com

Deputy Editor: Javier Carmona

Javier started his studies at the University of Navarra and received a degree in Biology from the Autonomous University of Madrid. In 2013, he obtained his Ph.D. after working in Manel Esteller's Cancer Epigenetics and Biology Program in Barcelona. Javier continued his research as a postdoctoral fellow in the group of José Baselga at the Memorial Sloan Kettering Cancer Center in New York, where he studied the mechanisms of resistance to therapy in patients with breast cancer. In 2016 he joined Nature Medicine.

javier.carmona@us.nature.com

Chief News Editor: Roxanne Khamsi

Before joining Nature Medicine, Roxanne Khamsi worked as an online reporter for New Scientist, writing daily stories about biomedical research. Her articles have also appeared in publications such as The Economist, Wired News and the MIT Technology Review. Roxanne earned a bachelor's degree in biology from Dartmouth College in Hanover, New Hampshire.

r.khamsi@us.nature.com

 

Senior Editor, Magazine: Marianne Guenot

Marianne received a PhD in microbiology and immunology at the University of Bordeaux, France, looking at Vγ9Vδ2 T cell reactions to Plasmodium falciparum (malaria) parasites. In her postdoctoral work at Imperial College London, UK, she used live imaging to compare the biophysical properties of actin recruitment in enteropathogenic Escherichia coli (EPEC) pedestal formation and phagocytosis. Developing a growing interest in how science is communicated beyond the realm of academic publishing, she then obtained a master’s degree in science communication at Imperial College London, followed by a brief stint as a freelance journalist before joining The Lancet as a senior editor overseeing the news section (World Report). She joined Nature Medicine in August 2019. She has expertise in public and global health, policy and the interface of medicine and society. You can follow her on Twitter @Marianne_Guenot.

marianne.guenot.1@nature.com

Senior Editor, Reviews and News & Views: Hannah Stower

Hannah completed her undergraduate degree in Molecular and Cellular Biochemistry at the University of Oxford. She then obtained her PhD in the laboratory of Bryan Turner at the University of Birmingham, UK, investigating the memory of histone modifications in cell division. Before joining Nature Medicine in 2013 she gained experience in genomics as a Senior Assistant Editor at Genome Biology and more broadly in genetics as Associate Editor at Nature Reviews Genetics.

h.stower@us.nature.com

Senior Editor, Research Manuscripts: Michael Basson

As a graduate student in Jasper Rine's laboratory at University of California at Berkeley, Michael studied the sterol biosynthetic pathway and its rate-limiting enzyme HMG-CoA reductase in baker's yeast. His postdoctoral work was on developmental genetics and microRNAs with Robert Horvitz at the Massachusetts Institute of Technology. He then worked in the biotech industry, first on the use of model organisms for drug discovery and then on tumor angiogenesis. Michael currently handles research manuscripts in the fields of cardiovascular disease & hematology, precision medicine & big data, and bioengineering & biotechnology. He joined Nature Medicine in 2003.

m.basson@us.nature.com

Senior Editor, Research Manuscripts: Alison Farrell

Alison Farrell pursued her undergraduate degree in microbiology and immunology at McGill University in Montreal, Quebec and received her Ph.D. from the University of California, San Francisco, where she studied cell cycle regulation in the laboratory of David O. Morgan. Alison subsequently joined LeukoSite in Cambridge, MA as a postdoctoral fellow. She did a second post-doctoral stint at Harvard Medical School before joining Nature Medicine in 2001. Alison is located in the San Francisco office.

a.farrell@us.nature.com

Senior Editor, Research Manuscripts: Kate Gao

Kate obtained her undergraduate degree in biological sciences from Nankai University in China. Prior to her doctoral work, Kate studied the genetic and molecular bases of neurodegenerative diseases at Baylor College of Medicine. Her PhD work in the laboratory of Songhai Shi at Memorial Sloan Kettering Cancer Center focused on the production and organization of excitatory neurons in the developing mammalian cortex. Kate began her editorial career at Nature Communications in 2015 and joined Nature Medicine in 2016.

kate.gao@us.nature.com

Associate Editor, Research Manuscripts: Saheli Sadanand

 

Saheli received her undergraduate degree in molecular biophysics and biochemistry from Yale College. She then joined the Yale Department of Immunobiology, where she studied flu-specific memory B cells. After obtaining her Ph.D., she investigated the programming and maintenance of isotype-specific B cells in HIV-infected patients as a post-doctoral fellow in the laboratory of Galit Alter at the Ragon Institute of MGH, MIT and Harvard. Saheli began her editorial career as Locum Associate Editor at Nature Biotechnology in 2018 and joined Nature Medicine in 2019. Saheli handles papers related to immunology, rheumatologic diseases and immunotherapies, including cancer immunotherapies. She can be followed on Twitter @SaheliSadanand

s.sadanand@us.nature.com

Senior Editor, Research Manuscripts: Jennifer Sargent

Jennifer completed her undergraduate degree in biochemistry at the University of Queensland in Brisbane, Australia. Prior to her doctoral work, Jennifer studied signal transduction systems in P. aeruginosa with Joanne Engel at the University of California, San Francisco, USA. She received her PhD from Dartmouth College for her studies on transcriptomics and genetics of scleroderma in Michael Whitfield’s lab. Jennifer did her postdoctoral work with Juan Rivera at the National Institutes of Health, USA, investigating sphingolipid signalling in allergy and autoimmunity. Jennifer has been serving the clinical and scientific communities as a professional editor since 2014. She was an editor at Nature Reviews Endocrinology before moving to The Lancet in 2015. In 2019, Jennifer joined the team at Nature Medicine as the editor for metabolism, physiology, global health, and public health. She is based in the London office and you can follow her on Twitter @JenLSargent

jennifer.sargent@nature.com

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug